Skip to main content

Secondary navigation:

Carroll School of Management

Christopher A. Viehbacher

Chief Executive Officer, Sanofi, and Chairman, Genzyme Corporation


Current and Future Innovations in the Worldwide Pharmaceutical and Health Care Industries

Sanofi Chief Executive Officer and Genzyme Corporation Chairman Christopher A. Viehbacher talked about his company’s local investments (Sanofi subsidiary Genzyme’s headquarters are in Cambridge), and called for new funding models for drug research at the March 6 Chief Executives’ Club of Boston. Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific, Inc., introduced Viehbacher.

TAKEAWAYS

“I think probably the most fertile ground [for innovation] in the world today is right here in the Boston-Cambridge area.” TRANSCRIPT AND VIDEO »

“Today, what we are seeing is that venture capital has largely dried up, particularly for start-up companies ... The science has never been more promising. It has never been more difficult to fund a new idea.” TRANSCRIPT AND VIDEO »

“To attract and retain global talent ... we’ve got to find the right balance between immigration and security. [Then we will be] able to have the brightest minds to help us do the innovation.” TRANSCRIPT AND VIDEO »

“I think you’re going to see [health care in] emerging markets actually leapfrog [health care in] Western markets … because they [don’t] have all of the prior investment in health care systems.” TRANSCRIPT AND VIDEO »

PRESS COVERAGE

Wall Street Journal (via Dow Jones): “Sanofi CEO: Drug industry needs new investment models” ARTICLE »

Reuters: “Sanofi CEO interested in emerging-market deals” ARTICLE »

Dow Jones MarketWatch: “What’s on Sanofi’s shopping list?” ARTICLE »

Mass High Tech: “Sanofi CEO to create jobs beyond Genzyme” ARTICLE »

Boston Globe: “Sanofi taking new approach to drug innovation, CEO says” ARTICLE »

Boston Business Journal: “Sanofi's Viehbacher vows Boston jobs beyond Genzyme” ARTICLE »

Boston Herald: “Sanofi chief Viehbacher affirms commitment to talent-rich Hub”
ARTICLE »

Event Photos
file
Christopher A. Viehbacher, Chief Executive Office of Sanofi and Chairman of Genzyme, addresses the Chief Executives' Club of Boston.
file
Seated at the Speakers Table (clockwise, from bottom left): Pat Purcell, President & Publisher, Boston Herald; Joseph Petrowski, Chief Executive Officer, Cumberland Farms Gulf Oil Group; Scott Griffith, Chief Executive Officer, Zipcar; Elizabeth Nabel, President, Brigham & Women’s Hospital; Marc Casper, President & CEO, Thermo Fisher Scientific; Christopher Viehbacher, Chief Executive Officer, Sanofi & Chairman, Genzyme; Kerry Healy, Former Lieutenant Governor, Commonwealth of Massachusetts; James Boyle, President, John Hancock Financial Services; Andrew Dreyfus, President & CEO, Blue Cross Blue Shield of MA; Theodore Lapres, President & CEO, Nypro; Henri Termeer, Former Chief Executive Officer, Genzyme
file
A "who's who" crowd is gathered at the Chief Executives' Club of Boston.
file
Members of the media speak with Mr. Viehbacher following his remarks.